Explorer Surgical Chosen by Pega Medical

Pega Medical leverages digital playbook with step-by-step procedural guide and interactive remote case support to enable optimal surgical outcomes

Explorer Surgical, a GHX company, has expanded its presence in the pediatric orthopedic medical device space with the announcement of its newest customer, Pega Medical. Specializing in the design, development, evaluation and manufacturing of medical devices for pediatric orthopedics, Pega Medical was founded in 1996 and its implantable devices reach children living with orthopedic conditions in more than 70 countries, including within multiple top-tier children’s hospitals.

Pega Medical’s medical device reps and senior-level clinical teams will now have access to Explorer Surgical’s digital case support platform that facilitates sharing procedural best practices remotely and real-time collaboration during live procedures.

Explorer Surgical’s innovative procedural playbooks, telementoring and performance tracking tools help providers and medical device companies better collaborate and drive procedural efficiencies and repeatable processes to enhance patient outcomes. In fact, a recent study from the Journal of Pediatric Orthopaedics cites “…the COVID-19 pandemic and its related countermeasures have had significant impacts on pediatric orthopaedic practice and increased uptake of technology to provide care continuity.” The impact the pandemic has had on this specialty demonstrates the immense need for technological integrations that can make procedures more efficient and teachable to give children optimal care and better outcomes.

“We believe the Explorer Surgical platform will modernize the way our clinical and field sales teams train and support surgeons and OR staff,” said Pega Medical VP of Product Development and Marketing Fady Rayes. “With clinical personnel located all over the world, the Explorer Surgical platform gives us the ability to connect and collaborate remotely and in real-time, providing our team with greater flexibility and efficiency, particularly when we are not on-site for a live case. Our primary focus is on the outcomes for the children receiving our implants and Explorer Surgical will be a tremendous asset in advancing our work.”

“Extending the highest quality care and the best possible outcome to all patients is at the heart of our mission, but it’s especially important for children as they are one of the most vulnerable patient populations,” said Explorer Surgical General Manager and Co-founder Jennifer Fried. “As a parent myself, there are few things as rewarding as helping a child live a fuller, healthier life. We are honored to help Pega Medical in its quest to put state-of-the-art technologies in the hands of surgeons who understand the unique complexities in caring for children.”

To learn more, join Pega Medical at booth #3663 (South Building) and Explorer Surgical at booth #118 (South Building) at the 2022 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting, taking place March 22-26 at the McCormick Place in Chicago.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version